- Home
- CENX vs DNLI Comparison
CENX vs DNLI Comparison
Compare CENX & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CENX | DNLI |
|---|---|---|
| Founded | 1995 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aluminum | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.5B |
| IPO Year | 1996 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CENX | DNLI |
|---|---|---|
| Price | $30.78 | $20.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 13 |
| Target Price | ★ $33.00 | $32.64 |
| AVG Volume (30 Days) | ★ 2.6M | 1.4M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.83 | N/A |
| Revenue | ★ $2,525,100,000.00 | N/A |
| Revenue This Year | $16.07 | N/A |
| Revenue Next Year | N/A | $94,232.03 |
| P/E Ratio | $37.06 | ★ N/A |
| Revenue Growth | ★ 20.15 | N/A |
| 52 Week Low | $13.05 | $10.57 |
| 52 Week High | $34.52 | $26.18 |
Technical Indicators
Market Signals| Indicator | CENX | DNLI |
|---|---|---|
| Relative Strength Index (RSI) | 56.86 | 68.58 |
| Support Level | $25.40 | $17.65 |
| Resistance Level | $30.19 | $19.63 |
| Average True Range (ATR) | 1.30 | 1.02 |
| MACD | 0.32 | 0.14 |
| Stochastic Oscillator | 90.20 | 95.82 |
Price Performance
Historical ComparisonAbout CENX Century Aluminum Company
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.